Kelly Bliss - 25 Sep 2024 Form 3 Insider Report for Teladoc Health, Inc. (TDOC)

Role
President, U.S. Group Health
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol
TDOC
Transactions as of
25 Sep 2024
Net transactions value
$0
Form type
3
Filing time
27 Sep 2024, 16:08:18 UTC
Next filing
02 Oct 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TDOC Common Stock 26,469 25 Sep 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TDOC Employee Stock Option (right to buy) 25 Sep 2024 Common Stock 58,782 $32.62 Direct F1
holding TDOC Restricted Stock Units 25 Sep 2024 Common Stock 2,631 Direct F2, F3
holding TDOC Restricted Stock Units 25 Sep 2024 Common Stock 2,808 Direct F3, F4
holding TDOC Restricted Stock Units 25 Sep 2024 Common Stock 20,928 Direct F3, F5
holding TDOC Restricted Stock Units 25 Sep 2024 Common Stock 58,300 Direct F3, F6
holding TDOC Performance Stock Units 25 Sep 2024 Common Stock 7,131 Direct F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vested as to one-third of the shares on June 1, 2023. The remainder of the shares vest in 24 substantially equal monthly installments thereafter.
F2 On October 1, 2021, the reporting person was granted 7,892 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
F3 Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F4 On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F5 On March 3, 2023, the reporting person was granted 41,853 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F6 On March 19, 2024, the reporting person was granted 58,300 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.
F7 On March 1, 2024, the reporting person earned 14,263 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F8 Performance stock units convert to shares of TDOC common stock on a one-for-one basis.

Remarks:

Exhibit 24 -- Power of Attorney